2019
DOI: 10.23888/pavlovj2019273325-332
|View full text |Cite
|
Sign up to set email alerts
|

A study of osteoprotective effect of l-arginine, l-norvaline and rosuvastatin on a model of hypoestrogen-induced osteoporosis in rats

Abstract: Effect on the microcirculatory bed of the bony tissue is one of promising approaches to treatment of osteoporosis. Aim. To study anti-osteoporotic properties of endothelioprotectors: L-arginine, L-norvaline and rosuvastatin. Materials and Methods. Osteoprotective properties of L-arginine, L-norvaline and rosuvastatin, and also of a reference drug– strontium ranelate – were studied on 152 female rats of Wistar line using a model of hypoestrogen-induced osteoporosis. Anti-osteoporotic and endotheliop… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 15 publications
0
1
0
Order By: Relevance
“…The development of generalized osteoporosis was assessed eight weeks (on day 57) after ovariectomy (Gudyrev et al 2019). The following groups were included in the design of the experiment: sham-operated animals (daily oral administration of saline); control group, simulating bilateral ovariectomy (OV); OV + LHT 21-16 at a dose of 50 mg/kg; OV + LHT 21-18 at a dose of 50 mg/kg; OV+ composition №1 at a dose of 50 mg/ kg); OV + alendronic acid (Alendronate) at a dose of 2.5 Each experimental group included 10 animals (Fig.…”
Section: Experimental Animalsmentioning
confidence: 99%
“…The development of generalized osteoporosis was assessed eight weeks (on day 57) after ovariectomy (Gudyrev et al 2019). The following groups were included in the design of the experiment: sham-operated animals (daily oral administration of saline); control group, simulating bilateral ovariectomy (OV); OV + LHT 21-16 at a dose of 50 mg/kg; OV + LHT 21-18 at a dose of 50 mg/kg; OV+ composition №1 at a dose of 50 mg/ kg); OV + alendronic acid (Alendronate) at a dose of 2.5 Each experimental group included 10 animals (Fig.…”
Section: Experimental Animalsmentioning
confidence: 99%